A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of o...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14a535e894574041ba6a7a01d70ccb93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:14a535e894574041ba6a7a01d70ccb93 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:14a535e894574041ba6a7a01d70ccb932021-12-02T12:31:50ZA screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E210.1038/s41598-017-04274-82045-2322https://doaj.org/article/14a535e894574041ba6a7a01d70ccb932017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04274-8https://doaj.org/toc/2045-2322Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of overlapping peptides covering E1E2. Screening the peptide library identified several novel anti-HCV peptides. Four peptides from glycoprotein E2 were selected for further investigation. The 50% effective dose (ED50) was approximately 5 nM for each peptide. Our data indicated that these peptides inhibited HCV entry at the post-attachment step. Moreover, these peptides blocked cell-to-cell transmission of HCVcc and had broad-spectrum antiviral effects on HCVcc. These peptides exhibited combination inhibitory effects on HCVcc infection when combined with IFN-α2b or anti-CD81 antibody. Interestingly, we observed that E2-42 associated with E1 and E2. Our results indicate that E2-42 inhibits HCV entry via E1 and E2. These findings suggest a new avenue for HCV therapeutic development.Peiqi YinLing ZhangFei YeYao DengSha LuYi-Ping LiLeiliang ZhangWenjie TanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Peiqi Yin Ling Zhang Fei Ye Yao Deng Sha Lu Yi-Ping Li Leiliang Zhang Wenjie Tan A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
description |
Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of overlapping peptides covering E1E2. Screening the peptide library identified several novel anti-HCV peptides. Four peptides from glycoprotein E2 were selected for further investigation. The 50% effective dose (ED50) was approximately 5 nM for each peptide. Our data indicated that these peptides inhibited HCV entry at the post-attachment step. Moreover, these peptides blocked cell-to-cell transmission of HCVcc and had broad-spectrum antiviral effects on HCVcc. These peptides exhibited combination inhibitory effects on HCVcc infection when combined with IFN-α2b or anti-CD81 antibody. Interestingly, we observed that E2-42 associated with E1 and E2. Our results indicate that E2-42 inhibits HCV entry via E1 and E2. These findings suggest a new avenue for HCV therapeutic development. |
format |
article |
author |
Peiqi Yin Ling Zhang Fei Ye Yao Deng Sha Lu Yi-Ping Li Leiliang Zhang Wenjie Tan |
author_facet |
Peiqi Yin Ling Zhang Fei Ye Yao Deng Sha Lu Yi-Ping Li Leiliang Zhang Wenjie Tan |
author_sort |
Peiqi Yin |
title |
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
title_short |
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
title_full |
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
title_fullStr |
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
title_full_unstemmed |
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2 |
title_sort |
screen for inhibitory peptides of hepatitis c virus identifies a novel entry inhibitor targeting e1 and e2 |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/14a535e894574041ba6a7a01d70ccb93 |
work_keys_str_mv |
AT peiqiyin ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT lingzhang ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT feiye ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT yaodeng ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT shalu ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT yipingli ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT leiliangzhang ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT wenjietan ascreenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT peiqiyin screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT lingzhang screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT feiye screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT yaodeng screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT shalu screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT yipingli screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT leiliangzhang screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 AT wenjietan screenforinhibitorypeptidesofhepatitiscvirusidentifiesanovelentryinhibitortargetinge1ande2 |
_version_ |
1718394260170997760 |